 One prospective use of these cells includes cellular therapies aimed at dropping inflammation and scarring.Models have shown that using these cells to reduce such inflammation has shown rewarding affects in the lungs and liver.More specifically, amniotic epithelial cells have been used in the past to treat genetic liver diseases such as ornithine transcarbamylase deficiency, familial hypercholesterolemia, and Crigler–Najjar syndrome.